Physician profile
Regina E Thurman
NPI 1689682353
$1,927.36
in general payments reported to CMS, 2019-2025
19 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $53.31 · 2021: $60.60 · 2022: $52.29 · 2023: $49.16 · 2024: $19.23 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $671 · Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $670.66 |
| Food and Beverage | $533.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,180.66 | 2021-2025 | Synchromedii |
| Pfizer INC. | $157.40 | 2019 | |
| Collegium Pharmaceutical, INC. | $111.81 | 2019-2025 | Belbuca, Xtampza |
| Daiichi Sankyo INC. | $89.23 | 2019 | |
| Medtronic USA, INC. | $83.56 | 2019-2020 | |
| Shionogi INC | $44.84 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.94 | 2019 | |
| Zyla Life Sciences, INC. | $39.95 | 2019 | |
| Amgen INC. | $31.20 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.76 | 2025 | |
| Valinor Pharma, LLC | $18.93 | 2025 | Movantik |
| Redhill Biopharma INC. | $17.21 | 2021 | |
| Abbott Laboratories | $14.98 | 2019 | |
| Boston Scientific Corporation | $14.07 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.01 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.96 | 2019 | |
| Biodelivery Sciences International, INC. | $11.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.36 | 2019 | |
| Neuronetics, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Thurman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.